LLY Jan 2025 350.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:01AM EDT. Market open.
| Previous close | 415.00 |
| Open | 400.00 |
| Bid | 440.00 |
| Ask | 445.75 |
| Strike | 350.00 |
| Expiry date | 2025-01-17 |
| Day's range | 400.00 - 400.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 212 |
ZacksBiogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
Biogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA for Leqembi subcutaneous autoinjector as a weekly maintenance dosing regimen for early Alzheimer's disease.
ZacksShould You Hold Viking Therapeutics (VKTX) in Your Portfolio?
Viking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous potential. However, existing competition from obesity drugs in the market remains a woe.
Investor's Business DailyIs Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Eli Lilly stock broke out and then retreated into sell-zone territory. With shares on the rise again, is LLY stock a buy?
© 2024 Yahoo. All rights reserved.